BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 26231219)

  • 1. Altering 5-hydroxymethylcytosine modification impacts ischemic brain injury.
    Miao Z; He Y; Xin N; Sun M; Chen L; Lin L; Li J; Kong J; Jin P; Xu X
    Hum Mol Genet; 2015 Oct; 24(20):5855-66. PubMed ID: 26231219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of 5-hydroxymethylcytosine in mitochondria after ischemic stroke.
    Ji F; Zhao C; Wang B; Tang Y; Miao Z; Wang Y
    J Neurosci Res; 2018 Oct; 96(10):1717-1726. PubMed ID: 30043506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insight into substrate preference for TET-mediated oxidation.
    Hu L; Lu J; Cheng J; Rao Q; Li Z; Hou H; Lou Z; Zhang L; Li W; Gong W; Liu M; Sun C; Yin X; Li J; Tan X; Wang P; Wang Y; Fang D; Cui Q; Yang P; He C; Jiang H; Luo C; Xu Y
    Nature; 2015 Nov; 527(7576):118-22. PubMed ID: 26524525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells.
    Putiri EL; Tiedemann RL; Thompson JJ; Liu C; Ho T; Choi JH; Robertson KD
    Genome Biol; 2014 Jun; 15(6):R81. PubMed ID: 24958354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
    Poole CJ; Lodh A; Choi JH; van Riggelen J
    Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic distribution and possible functions of DNA hydroxymethylation in the brain.
    Wen L; Tang F
    Genomics; 2014 Nov; 104(5):341-6. PubMed ID: 25205307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ten-eleven translocation proteins and 5-hydroxymethylcytosine in hepatocellular carcinoma.
    Wang P; Yan Y; Yu W; Zhang H
    Cell Prolif; 2019 Jul; 52(4):e12626. PubMed ID: 31033072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TET2-Mediated Spatiotemporal Changes of 5-Hydroxymethylcytosine During Organogenesis in the Late Mouse Fetus.
    Li X; Xie F; Jin J; Wu Y; Luo Z; Zhang F; Zhang S; Chen D; Liu A
    Anat Rec (Hoboken); 2019 Jun; 302(6):954-963. PubMed ID: 30369084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered 5-Hydroxymethylcytosine Landscape in Primary Gastric Adenocarcinoma.
    Liu H; Xu T; Cheng Y; Jin MH; Chang MY; Shu Q; Allen EG; Jin P; Wang X
    DNA Cell Biol; 2019 Dec; 38(12):1460-1469. PubMed ID: 31657619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of 5-hydroxymethylcytosine and TET2 in oral squamous cell carcinoma.
    Jäwert F; Hasséus B; Kjeller G; Magnusson B; Sand L; Larsson L
    Anticancer Res; 2013 Oct; 33(10):4325-8. PubMed ID: 24122999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of high 5-hydroxymethylcytosine levels with Ten Eleven Translocation 2 overexpression and inflammation in Sjögren's syndrome patients.
    Lagos C; Carvajal P; Castro I; Jara D; González S; Aguilera S; Barrera MJ; Quest AFG; Bahamondes V; Molina C; Urzúa U; Hermoso MA; Leyton C; González MJ
    Clin Immunol; 2018 Nov; 196():85-96. PubMed ID: 29894742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten eleven translocation enzymes and 5-hydroxymethylation in mammalian development and cancer.
    Kinney SR; Pradhan S
    Adv Exp Med Biol; 2013; 754():57-79. PubMed ID: 22956496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tet family proteins and 5-hydroxymethylcytosine in development and disease.
    Tan L; Shi YG
    Development; 2012 Jun; 139(11):1895-902. PubMed ID: 22569552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-eleven translocation 2 demethylates the
    Li X; Wu C; Shen Y; Wang K; Tang L; Zhou M; Yang M; Pan T; Liu X; Xu W
    J Biol Chem; 2018 Jun; 293(26):10059-10070. PubMed ID: 29773648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of DNA Hydroxymethylation Protects the Brain After Stroke.
    Morris-Blanco KC; Kim T; Lopez MS; Bertogliat MJ; Chelluboina B; Vemuganti R
    Stroke; 2019 Sep; 50(9):2513-2521. PubMed ID: 31327315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells.
    Calabrese R; Valentini E; Ciccarone F; Guastafierro T; Bacalini MG; Ricigliano VA; Zampieri M; Annibali V; Mechelli R; Franceschi C; Salvetti M; Caiafa P
    Biochim Biophys Acta; 2014 Jul; 1842(7):1130-6. PubMed ID: 24735979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PGC7 binds histone H3K9me2 to protect against conversion of 5mC to 5hmC in early embryos.
    Nakamura T; Liu YJ; Nakashima H; Umehara H; Inoue K; Matoba S; Tachibana M; Ogura A; Shinkai Y; Nakano T
    Nature; 2012 Jun; 486(7403):415-9. PubMed ID: 22722204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Hydroxymethylcytosine: a stable or transient DNA modification?
    Hahn MA; Szabó PE; Pfeifer GP
    Genomics; 2014 Nov; 104(5):314-23. PubMed ID: 25181633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sweet TET-à-tête-synergy of TET proteins and O-GlcNAc transferase in transcription.
    Mariappa D; Pathak S; van Aalten DM
    EMBO J; 2013 Mar; 32(5):612-3. PubMed ID: 23403924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5mC oxidation by Tet2 modulates enhancer activity and timing of transcriptome reprogramming during differentiation.
    Hon GC; Song CX; Du T; Jin F; Selvaraj S; Lee AY; Yen CA; Ye Z; Mao SQ; Wang BA; Kuan S; Edsall LE; Zhao BS; Xu GL; He C; Ren B
    Mol Cell; 2014 Oct; 56(2):286-297. PubMed ID: 25263596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.